Figure 8E shows a decrease in the expression of the NTRK1- FLI1/ETV1/ERG gene fusions compared to normal tissue. The downregulation of NTRK1 has been detected in several cancers, such as PCa and breast cancer, which lead to tumor progression [84]. This evidence concerns the gene ERG and breast cancer.